Novo Nordisk developed CagriSema as the successor to their blockbuster semaglutide therapy, recognizing that even 2.4 mg of standalone semaglutide left room for improvement
In trials for MASH, survodutide demonstrated significant reduction in liver fat and improvement in liver fibrosis scores
: The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials Hadis Fathizadeh et al
Statement #10: weak recommendation, low quality evidence (2C) Ammonia scavenger therapy needs to be continued during dialysis
Evidence that 2 -adrenergic pathways play a major role in growth hormone [GH] neuroregulation: 2 -adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while a2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men
The controlled composition and sterile preparation allow the solution to be used in experimental protocols requiring high-purity solvent systems